Don't want ads? Subscribe or login now.

FDA Dodges Suit Over Ozempic, Wegovy Listing

By Adam Lidgett · June 18, 2025, 6:41 PM EDT

The U.S. Food and Drug Administration was able to escape allegations that it catered to Big Pharma by nixing cheaper versions of the miracle weight loss drug Ozempic, after a Texas...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Outsourcing Facilities Association et al v. Food and Drug Administration et al

Case Number

4:25-cv-00174

Court

Texas Northern

Nature of Suit

Other Statutes: Administrative Procedure Act/Review or Appeal of Agency Decision

Date Filed

February 24, 2025

Recent Articles By Adam

June 03, 2025
Patent Deals Accelerate Access To Generics, Drug Group Says
April 11, 2025
Foreign Cos. Say Anti-Choking Device Patent Is Invalid
April 11, 2025
Aurinia Sues Lotus Alleging Lupus Drug Patent Infringement
April 08, 2025
Pacira Reaches IP Deal Allowing Generic Painkiller In 2030
April 07, 2025
Incyte Can't Get Pretrial Win In Novartis Royalty Fight
April 03, 2025
Texas Appeals Court Backs UT Royalty Award In Pet Co. Suit
March 27, 2025
Fitch Even Sues Ex-IP Client In Effort To End Malpractice Case
March 24, 2025
Amgen Wants $50M Leukemia Drug Patent Verdict Thrown Out
March 18, 2025
Bausch Eye Vitamin Case Should Go To Jury, Judge Says
March 18, 2025
AI Healthcare Co. Accuses Test-Maker Of Infringing Patents